Onward Medical N.V. (BST:63E)

Market Cap	150.90M -19.6%
Revenue (ttm)	8.42M +210.1%
Net Income	-45.27M
EPS	-0.85
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	2.240
Previous Close	2.240
Day's Range	2.120 - 2.240
52-Week Range	2.025 - 4.880
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 3, 2026

About Onward Medical

Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with spinal cord injury (SCI) in the United States, Europe, and internationally. The company offers ARCEX System, an external stimulator that is intended to improve hand strength and sensation following SCI; ARCIM System, an implantable system currently used to explore potential indications in clinical feasibility studies; ARCBCI System, an implantable system currently being investigated to enable thought driven move...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2014
• Employees: 137
• Stock Exchange: Stuttgart Stock Exchange
• Ticker Symbol: 63E

Financial Performance

In 2025, Onward Medical's revenue was 5.41 million, an increase of 211.33% compared to the previous year's 1.74 million. Losses were -41.79 million, 17.0% more than in 2024.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 30, 2026

Data Sources Report a data error